Clarimax™ Plus Cream – Advanced Skin Brightening & Clarifying Formula (30gm)
₨ 1,510
11 in stock
11 in stock
ادائیگی کے طریقے:
تفصیل
Clarimax™ Plus is an advanced dermatological cream specially formulated to help brighten the skin, reduce pigmentation, and improve overall skin clarity. It works effectively on dark spots, acne marks, and uneven tone, making it ideal for those seeking a visibly clearer, smoother, and healthier complexion.
Key Features & Benefits
-
Brightens and evens out skin tone
-
Reduces dark spots, melasma, and post-acne marks
-
Improves skin texture and radiance
-
Lightweight, non-greasy, and fast-absorbing formula
-
Suitable for all skin types, including oily and acne-prone skin
-
Ideal for daily use by both men and women
Why Use Clarimax™ Plus Cream?
-
Combats common pigmentation issues effectively
-
Helps restore a balanced, even-toned complexion
-
Supports skin regeneration and clarity
-
Recommended for dull, discolored, or spot-prone skin
-
Can be used as part of a brightening or acne mark-fading routine
How to Use
-
Cleanse your face and pat dry
-
Apply a small amount to the affected areas or entire face
-
Gently massage until absorbed
-
Use twice daily (morning and night) for best results
-
Apply sunscreen during the day to protect treated skin
Things to Avoid
-
Avoid contact with eyes and lips
-
Do not apply on broken, irritated, or sunburned skin
-
Avoid mixing with other strong active treatments unless directed
-
Discontinue use if excessive redness or irritation occurs
-
Store in a cool, dry place away from sunlight…
صارف کے جائزے
متعلقہ مصنوعات
Fa Brightening Roll-On – Violet & Jasmine (50ml)
اسٹاک میں
Fa Men Freshly Free Roll-On – Mint & Bergamot (50ml)
اسٹاک میں
Fa Mystic Moments Roll-On – Passion Flower Scent & 48h Protection (50ml)
اسٹاک میں
Nivea Creme Moisturizer 250ml – Intensive All-Purpose Skin Care Tin
اسٹاک میں
The Ordinary (Retinol 0.2% in Squalane) 30ml
اسٹاک میں
YC Whitening Face Wash Milk Extract – 100ml Mild Formula for Glowing Skin
اسٹاک میں



جائزے
فلٹرز صاف کریںابھی تک کوئی جائزہ نہیں ہے۔